Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
25 mars 2025 11h25 HE
|
Organovo, Inc.
SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment...
CORRECTION – Global Reach for Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
24 mars 2025 21h51 HE
|
Avance Clinical
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
Master Biotech Basics: Non-Biotechnologist Training Course Covers Regulations, Patents & Innovations - Join the CPD-Certified Online Training Course on 9-11 July 2025
20 mars 2025 12h30 HE
|
Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Biotechnology for the Non-Biotechnologist Training Course (ONLINE EVENT: July 9-11, 2025)" has been added to ResearchAndMarkets.com's offering. The...
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
16 mars 2025 19h15 HE
|
Avance Clinical
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
Tissue Clearing Market Research 2024-2034: Trends Analysis of Miniaturization and Portable Systems, 3D Printing for Customized Solutions, and Open-Source Platforms and Collaboration
13 mars 2025 10h53 HE
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Tissue Clearing Market by Product, by Tissue Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's...
Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World Experience of IgA Nephropathy
13 mars 2025 08h03 HE
|
Folia Health
BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home observational real-world evidence...
Pharmacovigilance Market Forecast to Surge to $24.76 Billion by 2030, Creating Lucrative Opportunities for Digital Transformation in Drug Safety
13 mars 2025 07h43 HE
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market by Type (Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting), Product Life Cycle (Phase I, Phase II, Phase III),...
Trump-era and JFK Jr Administration Drug Development & Outsourcing Impact Report 2025 Featuring IQVIA, Catalent, WuXi, Charles River, Fortrea, ICON, Lonza, Parexel, Syneos Health, Thermo Fisher
13 mars 2025 06h15 HE
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Trump-era Administration Drug Development & Outsourcing Impact Report 2025" report has been added to ResearchAndMarkets.com's offering. This...
Generative AI in Drug Discovery and Development Process Course: FDA Embraces Generative AI to Propel Drug Discovery and Development Forward (ONLINE EVENT: April 2, 2025 & ON-DEMAND)
10 mars 2025 08h30 HE
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Generative AI in Drug Discovery" training has been added to ResearchAndMarkets.com's offering. The US FDA's encouragement of AI technology in...
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises
06 mars 2025 08h05 HE
|
Organovo, Inc.
SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment...